From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer
White | Black | |||||
---|---|---|---|---|---|---|
O/E | Excess risk | Mean age at event | O/E | Excess risk | Mean age at event | |
All sites | 2.25# | 66 | 50.07 | 2.99# | 96.46 | 48.24 |
All solid tumors | 2.29# | 63.39 | 50.01 | 3.08# | 91.44 | 48.18 |
Oral cavity and pharynx | 2.35# | 1.06 | 51.39 | 1.91 | 0.75 | 54.79 |
Digestive system | 1.09 | 0.54 | 52.48 | 0.87 | −1.07 | 49.84 |
Colon, rectum and anus | 0.81 | −0.68 | 51.86 | 0.85 | −0.77 | 49.24 |
Pancreas | 0.85 | −0.12 | 47.3 | 0.37 | −0.66 | 46.42 |
Peritoneum, omentum and mesentery | 8.12# | 0.77 | 53.12 | 14.86# | 0.73 | 53.09 |
Respiratory system | 1.43# | 1.9 | 52.75 | 1.99# | 5.44 | 50.75 |
Bones and joints | 2.71 | 0.15 | 55.17 | 0 | −0.07 | |
Soft tissue including heart | 4.07# | 0.91 | 52.07 | 1.07 | 0.03 | 32.57 |
Skin excluding basal and squamous | 1.21 | 0.73 | 50.86 | 1.47 | 0.12 | 61.09 |
Breast | 3.31# | 48.31 | 49.09 | 5.16# | 78.93 | 47.01 |
Female genital system | 2.16# | 8.9 | 51.33 | 2.21# | 7.06 | 53.27 |
Corpus and uterus, NOS | 1.39# | 1.59 | 54.44 | 2.06# | 2.82 | 57.54 |
Ovary | 4.60# | 6.89 | 49.84 | 3.85# | 3.48 | 47.03 |
Urinary system | 1.4 | 0.78 | 51.42 | 0.45 | −0.95 | 54.83 |
Brain and other nervous system | 1.09 | 0.06 | 51.41 | 1.14 | 0.05 | 58.33 |
Endocrine system | 1.04 | 0.12 | 47.93 | 1.61 | 1.04 | 44.75 |
Lymphoma | 1.07 | 0.14 | 53.84 | 1.09 | 0.16 | 53.3 |
Leukemia | 3.00# | 1.82 | 47.71 | 8.48# | 5.18 | 47.61 |